 compliance measures applications ambulatory hypertensive drug trial value improved monitoring medication-taking behavior drug trial pill vial microcircuitry precise times vials placebo washout period ambulatory subjects mild hypertension mean age years men white isradipine twice double-blind titration weeks drugs reduction diastolic blood pressure minimal symptomatic laboratory toxicity pill counts near-perfect compliance groups electronic monitor half openings prescribed interval hours overdispensing days visits monitor pill count compliance sufficiency visits discrete attribution drug-associated adverse reactions secondary resistance treatment electronic monitor reduces ambiguity medication compliance biology pharmacology trial